Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection
- Hisham Abdel-Azim
- , Kris Michael Mahadeo
- , Quan Zhao
- , Sajad Khazal
- , Donald B. Kohn
- , Gay M. Crooks
- , Ami J. Shah
- , Neena Kapoor
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Scopus
citations